FDA Approved: KIONEX — Supplemental Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approves a supplemental application for KIONEX (sodium polystyrene sulfonate) submitted by ANI Pharmaceuticals, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperkalemia

Drugs mentioned

• KIONEX (Sodium polystyrene sulfonate)

Snippet

SUPPL AP for KIONEX (SODIUM POLYSTYRENE SULFONATE)